Douglas Joint Ventures Pty Ltd is a limited by shares, Australian proprietary company. This corporation was registered on 1994-06-27 and was issued with the 065368381 ACN. Its Australian Business Number is 82065368381. Since 2014-09-21, the company is headquartered in QLD, post code 4007. The previous headquarters were located in QLD 4007 (from 2014-01-13 to 2014-09-21), QLD 4007 (from 2000-08-07 to 2014-01-13). Douglas Joint Ventures Pty Ltd has been using the Douglas Joint Ventures Pty Ltd trading name since 2000-08-07 (it should be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The company has also used 1 business name, namely Black Ink Developments from 2014-05-23 to 2016-01-16. The above data comes from the ABN database which was updated on 2022-10-07.
Status | From | To |
---|---|---|
Cancelled | 7th October 2022 | current |
Active | 13th May 2000 | 7th October 2022 |
Name | From | To |
---|---|---|
Douglas Joint Ventures Pty Ltd | 13th May 2000 | current |
Name | From | To |
---|---|---|
Black Ink Developments | 23rd May 2014 | 16th January 2016 |
Name | From | To |
---|---|---|
Douglas Joint Ventures Pty Ltd | 7th August 2000 | current |
Location | From | To |
---|---|---|
QLD 4007 | 21st September 2014 | current |
QLD 4007 | 13th January 2014 | 21st September 2014 |
QLD 4007 | 7th August 2000 | 13th January 2014 |
Advertisements
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.